A review on the role of CASC11 in cancers

Affiliation
Department of Medical Genetics ,School of Medicine ,Shahid Beheshti University of Medical Sciences ,Tehran ,Iran
Ghafouri-Fard, Soudeh;
Affiliation
Phytochemistry Research Center ,Shahid Beheshti University of Medical Sciences ,Tehran ,Iran
Harsij, Atefeh;
Affiliation
Department of Clinical Analysis ,College of Pharmacy ,Hawler Medical University ,Erbil ,Iraq
Hussen, Bashdar Mahmud;
GND
1249707153
Affiliation
Institute of Human Genetics ,Jena University Hospital ,Jena ,Germany
Taheri, Mohammad;
Affiliation
Skull Base Research Center ,Loghman Hakim Hospital ,Shahid Beheshti University of Medical Sciences ,Tehran ,Iran
Sharifi, Guive

The long non-coding RNA (lncRNA) cancer susceptibility 11 (CASC11) is a newly identified lncRNA located on chromosome 8q24.21. The expression of lncRNA CASC11 has been found to be elevated in different cancer types and the prognosis of the tumor is inversely correlated with the high CASC11 expression. Moreover, lncRNA CASC11 has an oncogenic function in cancers. The biological characteristics of the tumors, such as proliferation, migration, invasion, autophagy, and apoptosis can be controlled by this lncRNA. In addition to interacting with miRNAs, proteins, transcription factors, and other molecules, the lncRNA CASC11 modulates signaling pathways including Wnt/β-catenin and epithelial-mesenchymal transition. In this review, we have summarized studies on the role of lncRNA CASC11 in the carcinogenesis from cell lines, in vivo , and clinical perspectives.

Cite

Citation style:
Could not load citation form.

Rights

License Holder: Copyright © 2023 Ghafouri-Fard, Harsij, Hussen, Taheri and Sharifi.

Use and reproduction: